Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of Sunday, July 26, 2026.
Forward PE Ratio (N/A) = Close Price ($28.09) / Consensus Forward EPS ($-0.12)
FORWARD PE RATIO
N/A
Hims & Hers Health, Inc.
Market Cap
$6.27B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $6.27B | N/A |
| Oscar Health, Inc. (OSCR)vs › | $7.31B | 25.83 |
| Tempus AI, Inc. (TEM)vs › | $7.47B | N/A |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.50B | 34.78 |
| Henry Schein, Inc. (HSIC)vs › | $9.74B | 15.99 |
| Universal Health Services, Inc. (UHS)vs › | $9.75B | 6.64 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.59B | 9.12 |
| TransMedics Group, Inc. (TMDX)vs › | $2.50B | 40.06 |
| Molina Healthcare, Inc. (MOH)vs › | $10.31B | N/A |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 7.65 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus next-FY EPS
At today's $28.09 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.12 | $-0.12 – $-0.12 | 2 | n/m |
| 2027-12-31 | $0.47 | $0.28 – $0.62 | 3 | 60.3x |
| 2028-12-31 | $0.78 | $0.76 – $0.80 | 1 | 36.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
